EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey

Lovel Lisac, Angelo Roberto Raccagni iD, Riccardo Lolatto iD, Flavia Passini, Chiara Maci iD, Elena Bruzzesi iD, Nicolò Moschetta, Antonella Castagna, Silvia Nozza iD

Viruses · 2024

DOI: 10.3390/v16111789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Lovel Lisac und 8 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy. Hauptthemen laut MEDLINE: Herpes Genitalis, Herpesvirus 1, Human. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genital herpes simplex virus (HSV) is associated with a reduction in quality of life and adverse outcomes. The aim of this study is to assess the interest and expectations for a therapeutic HSV vaccine among individuals diagnosed with genital herpes in Italy. A retrospective survey was conducted at the Infectious Diseases Unit of the IRCCS San Raffaele Scientific Institute, Milan, Italy. The study collected data on demographics, clinical history and interest in HSV vaccination. The results showed that 87.5% of participants were interested in a therapeutic vaccine, with interest higher among younger people and those with frequent genital herpes recurrences. Participants most expected the vaccine to reduce the pain associated with outbreaks, followed by a reduction in the frequency and duration of recurrences. These findings underscore the strong demand for a therapeutic HSV vaccine, especially among those who experience recurrent outbreaks, and highlight the importance of considering patient expectations when developing preventive and therapeutic strategies for genital herpes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes GenitalisHerpesvirus 1, HumanHumansItalyFemaleAdultMaleMiddle AgedRetrospective StudiesSurveys and QuestionnairesYoung AdultHerpesvirus 2, HumanAgedHerpes Simplex Virus VaccinesAdolescentVaccinationQuality of LifeHerpesvirus Vaccines

Stichwörter der Autor:innen

HSV vaccineHSV-1HSV-2genital herpesherpes simplex virussexually transmitted infectionsurveytherapeutic vaccine

Substanzen

Herpes Simplex Virus VaccinesHerpesvirus Vaccines

Autor:innen und Institutionen

  • Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy.
  • Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.

ORCID-Profile: Angelo Roberto Raccagni, Riccardo Lolatto, Chiara Maci, Elena Bruzzesi, Silvia Nozza

Zitieren

APA

Lisac, L., Raccagni, A. R., Lolatto, R., Passini, F., Maci, C., Bruzzesi, E., Moschetta, N., Castagna, A., & Nozza, S. (2024). Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey. Viruses. https://doi.org/10.3390/v16111789

Vancouver

Lisac L, Raccagni AR, Lolatto R, Passini F, Maci C, Bruzzesi E, et al. Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey. Viruses. 2024. doi:10.3390/v16111789

BibTeX
@article{Lisac2024,
  author = {Lisac, Lovel and Raccagni, Angelo Roberto and Lolatto, Riccardo and Passini, Flavia and Maci, Chiara and Bruzzesi, Elena and Moschetta, Nicolò and Castagna, Antonella and Nozza, Silvia},
  title = {Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16111789}
}
Kostenlos starten →